Are you Dr. Patel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 774-442-3903Fax+1 508-334-1977
Summary
- Dr. Shyam Patel, MD is an oncologist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California. He is affiliated with UMass Memorial Medical Center.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2019- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2013 - 2016
Rutgers New Jersey Medical SchoolClass of 2013
Certifications & Licensure
MA State Medical License 2019 - 2025
CA State Medical License 2014 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis.Yiyu Xie, Vera Kazakova, Lachelle D Weeks, Jonathan M Gerber, Jesse Tai
Bone Marrow Transplantation. 2024-11-01 - Translational insights into the genetics and immunobiology of relapsed/refractory follicular lymphoma.Benyamin Yaniv, Benjamin Tanenbaum, Vera Kazakova, Shyam A Patel
Leukemia Research. 2024-07-01 - Frameshift Mutations in Leukemia-Associated Genes Correlate With Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant forAcute Myeloid Leukemia.Emma Cammann, Sindha Madhav, Lloyd Hutchinson, Jan Cerny, Muthalagu Ramanathan
Journal of Hematology. 2024-06-01
Press Mentions
- A Model for SuccessOctober 19th, 2020
Elevated MDS/AML Risk Post-Chemotherapy for 22 of 23 Solid CancersDecember 26th, 2018- Increased Risk of Chemo-Associated AML for Nearly All Solid CancersDecember 20th, 2018
